Ashish Kacholia Portfolio: Fineotex Chemical Shares Gain After Promoter Increases Stake
Ashish Kacholia Portfolio: Fineotex Chemical Shares Gain After Promoter Increases StakeMumbai: Shares of Fineotex Chemical, a specialty chemicals company, edged higher on Friday after one of its promoters increased their stake in the firm. The stock, which is part of ace investor Ashish Kacholia’s portfolio, rose 2.6% to ₹244.45 per share on the Bombay Stock Exchange (BSE).
Promoter Increases Stake in Fineotex Chemical
As per a regulatory filing, Sanjay Tibrewala, a promoter of Fineotex Chemical, purchased 20,000 equity shares of the company via open market transactions on March 6, 2025. The total value of this purchase was ₹41.31 lakh.
Before this transaction, Tibrewala held 34,34,900 shares, representing a 3% stake in the company. Following the acquisition, his stake has slightly increased to 3.02%, with a total of 34,54,900 shares.
As of December 2024, the promoter and promoter group collectively held 62.86% of Fineotex Chemical, while the remaining 37.14% was owned by public shareholders.
Ashish Kacholia’s Investment in Fineotex Chemical
Renowned investor Ashish Kacholia, known for his picks in small- and mid-cap stocks, owns 31,35,568 shares of Fineotex Chemical, accounting for a 2.7% stake in the company as of December 2024. His holding is currently valued at ₹74.8 crore.
Stock Performance and Market Trends
Despite the recent uptick in stock price, Fineotex Chemical has witnessed a significant correction over the past year. The stock has:
- Dropped 16% in the last one month
- Declined 34% in the past six months
- Fallen 39% over the past year
However, long-term investors have enjoyed multibagger returns, with the stock surging 1,043% over the last five years.
As of 12:05 PM on Friday, shares of Fineotex Chemical were trading 0.65% higher at ₹239.75 on the BSE.
Fineotex Chemical: Financial Snapshot
Below is a detailed look at the company’s key financial ratios and stock performance metrics:
| Metric | Value |
|---|---|
| Market Cap | ₹2,737 Cr. |
| Current Price | ₹239 |
| 52-Week High/Low | ₹439 / ₹218 |
| Stock P/E | 23.1 |
| Book Value | ₹60.2 |
| Dividend Yield | 0.67% |
| Return on Capital Employed (ROCE) | 38.7% |
| Return on Equity (ROE) | 30.1% |
| Face Value | ₹2.00 |
| Promoter Holding | 62.9% |
| Price to Book Value | 4.00 |
| Debt to Equity | 0.00 |
| Pledged Percentage | 0.00% |
| Industry P/E | 29.5 |
| Graham Number | ₹119 |
| Intrinsic Value | ₹203 |
| Relative Strength Index (RSI) | 34.4 |
| Earnings Per Share (EPS) | ₹10.5 |
| Number of Equity Shares | 11.5 Cr. |
| PEG Ratio | 0.58 |
| 200-Day Moving Average (DMA) | ₹336 |
| Free Cash Flow (Last 3 Years) | ₹128 Cr. |
| Free Cash Flow (Last 5 Years) | ₹135 Cr. |
| Free Cash Flow (Current Year) | ₹49.5 Cr. |
| Total Debt | ₹0.39 Cr. |
| Return on Assets | 24.9% |
Outlook on Fineotex Chemical
Fineotex Chemical operates in the specialty chemicals and enzyme sector, catering to industries like textiles, leather, construction, water treatment, and more. Given its strong fundamentals, debt-free status, and healthy cash flows, the stock remains a long-term wealth creator despite recent corrections.
The increase in promoter stake is often seen as a positive signal, indicating confidence in the company’s future growth prospects. Investors should keep an eye on upcoming quarterly results, sector performance, and technical trends before making any investment decisions.
Conclusion
With Ashish Kacholia’s backing, a strong promoter holding, and multibagger returns over the years, Fineotex Chemical continues to be a key stock in the specialty chemicals space. While the short-term trend remains weak, the company’s financial strength and growth potential make it a stock to watch for long-term investors.
For more market insights, follow our news.
Stay tuned for more updates and insights on the stock market! For more insights on investing in the Indian stock market, check out resource like ET, NSE India.
Disclaimer: This blog post is for informational purposes only and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified financial advisor before making any investment decisions.